Evelo Biosciences, Inc. (EVLO)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | 108.46 Million | 115.39 Million | 91.88 Million | 86.35 Million | 58.1 Million | 27.53 Million |
| Selling, General and Administrative Expenses | 29.91 Million | 31.75 Million | 22.27 Million | 23.22 Million | 18.21 Million | 7.57 Million |
| Research and Development Expenses | 78.55 Million | 83.64 Million | 69.61 Million | 63.12 Million | 39.88 Million | 19.95 Million |
| Other Expenses | - | 486 Thousand | -1.37 Million | 1.07 Million | 1.15 Million | -301 Thousand |
| Cost and Expenses | 108.46 Million | 115.39 Million | 91.88 Million | 86.35 Million | 58.1 Million | 27.53 Million |
| Operating Income | -108.46 Million | -115.39 Million | -91.88 Million | -86.35 Million | -58.1 Million | -27.53 Million |
| Interest Expense | 4.67 Million | 3.61 Million | 2.1 Million | 1.04 Million | 1.56 Million | - |
| Income Tax Expense | 930 Thousand | 428 Thousand | 409 Thousand | 190 Thousand | -3.09 Million | 215 Thousand |
| Earnings before Tax | -113.59 Million | -121.74 Million | -93.25 Million | -85.47 Million | -56.94 Million | -28.04 Million |
| Net Income | -114.52 Million | -122.17 Million | -93.66 Million | -85.66 Million | -53.85 Million | -28.04 Million |
| Earnings Per Share Basic | -26.28 | -46.18 | -47.45 | -53.49 | -49.25 | -149.98 |
| Earnings Per Share Diluted | -26.28 | -46.18 | -47.45 | -53.49 | -49.25 | -149.55 |
| Weighted Average Shares Outstanding | 4.35 Million | 2.64 Million | 1.97 Million | 1.6 Million | 1.09 Million | 187 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 4.35 Million | 2.64 Million | 1.97 Million | 1.6 Million | 1.09 Million | 187.54 Thousand |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -106.34 Million | -115.39 Million | -91.88 Million | -86.35 Million | -58.1 Million | -26.69 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 | 2022 Q3 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 793 Thousand | 1.61 Million | - | - | - | - |
| Gross Profit | -793 Thousand | -1.61 Million | - | - | - | - |
| Operating Expenses | 10.39 Million | 17.95 Million | 24.9 Million | 108.46 Million | 21.08 Million | 29.05 Million |
| Selling, General and Administrative Expenses | 3.89 Million | 4.91 Million | 7.04 Million | - | 5 Million | 7.12 Million |
| Research and Development Expenses | 6.49 Million | 13.04 Million | 17.85 Million | - | 16.08 Million | 21.92 Million |
| Other Expenses | -27 Thousand | 69 Thousand | 188 Thousand | 61 Thousand | 447 Thousand | -615 Thousand |
| Cost and Expenses | 11.18 Million | 17.95 Million | 24.9 Million | 108.46 Million | 21.08 Million | 29.05 Million |
| Operating Income | -11.18 Million | -19.57 Million | -24.9 Million | -108.46 Million | -21.08 Million | -29.05 Million |
| Interest Expense | -1.16 Million | 1.36 Million | 1.11 Million | 4.67 Million | 1.83 Million | 788 Thousand |
| Income Tax Expense | 17 Thousand | 233 Thousand | 145 Thousand | 930 Thousand | 544 Thousand | 107 Thousand |
| Earnings before Tax | -12.38 Million | -20.87 Million | -25.19 Million | -113.59 Million | -22.99 Million | -30.45 Million |
| Net Income | -12.36 Million | -21.1 Million | -25.34 Million | -114.52 Million | -23.54 Million | -30.56 Million |
| Earnings Per Share Basic | -0.71 | -3.78 | -4.57 | - | -4.29 | -5.66 |
| Earnings Per Share Diluted | -0.71 | -3.78 | -4.57 | - | -4.29 | -5.66 |
| Weighted Average Shares Outstanding | 17.38 Million | 5.57 Million | 5.54 Million | 4.35 Million | 5.49 Million | 5.4 Million |
| Weighted Average Shares Outstanding (Diluted) | 17.38 Million | 5.57 Million | 5.54 Million | 4.35 Million | 5.49 Million | 5.4 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -11.18 Million | -17.46 Million | -24.26 Million | - | -20.64 Million | -29.18 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
601003
GRVO
BGRIM
202A
4275
IEX